fda compounded tirzepatide warning 2024 2025 Drug Recalls and Warnings: Recalls for Semaglutide and Tirzepatide, Wegovy; Facility Letters Have patients been harmed by

Key Takeaways Tirzepatide is a once-weekly injection that targets two hunger hormones at the same time something no weight loss drug had done before it

Salvestrini, V., Sell, C

By activating both GIP and GLP-1 receptors, tirzepatide enhances insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and reduces appetite

Some users benefit from over-the-counter antiemetics like dimenhydrinate or meclizine taken prophylactically before injections

some investigators even suggest GLP-1 receptor and GIP receptor agonists might reduce inflammation in osteoarthritis, but evidence remains preliminary